Technology

Latest News

April 1st 2016

SXSW 2016 & The New Alchemy of Hope

In many life situations, it’s difficult to be hopeful. But at SxSW Interactive last week, it was difficult to be pessimistic, writes Bill Drummy.

March 31st 2016

EMA Publishes Parallel Scientific Advice Report

March 31st 2016

US Opioid Market to Reach $17.7 Billion by 2021, Says Report

March 29th 2016

Is the United Nations Declaring War on Biopharmaceutical Patents?

By Steven Tepp

March 29th 2016

President Obama to Address Rx Drug Abuse Summit

FDA Moves to Increase Development of and Access to Abuse-deterrent Opioids

March 24th 2016

March 24, 2016.

Pfizer Joins the Human Vaccines Project

ByPharmaceutical Technology

March 23rd 2016

Pharmaceutical Executive

March 23, 2016.

UK: Industry Likely to Pay for NICE Technology Assessments

ByLeela Barham

March 21st 2016

March 21, 2016

EMA Will Increase Fees on April 1

ByApplied Clinical Trials Editorial Staff

March 18th 2016

Pharmaceutical Executive

March 18, 2016.

Trusting Value, Valuing Trust

ByJulian Upton

March 18th 2016

Pharm Exec talks value-based healthcare with Professor Bengt Jönsson of the Stockholm School of Economics.

WHO Emergency Committee Holds Second Meeting on Zika Virus

ByPharmaceutical Technology

March 11th 2016

Pharmaceutical Executive

March 11, 2016.

Califf Seeks Clinical Trials That Inform Product Labels

ByJill Wechsler, Pharm Exec’s Washington Correspondent

March 10th 2016

Pharmaceutical Executive

March 10, 2016.

EGA Becomes Medicines for Europe

March 10th 2016

March 10, 2016.

EMA Launches Priority Medicines Scheme

March 7th 2016

March 07, 2016.

Drug Delivery Roundtable: More than the Pill

ByWilliam Looney

March 6th 2016

Pharmaceutical Executive

Can novel drug delivery technologies offering options beyond the traditional tablet or syringe transform the therapeutic experience for patients?

New Study Examines Overspending on Oversized Cancer Drug Vials

March 4th 2016

Pharmaceutical Executive

March 04, 2016.

FDA to Address Opioid Trial Challenges

ByJill Wechsler, Pharm Exec’s Washington Correspondent

March 3rd 2016

March 03, 2016.

New Strategies Needed to Clarify Off-Label Marketing

ByJill Wechsler, Pharm Exec’s Washington Correspondent

March 2nd 2016

March 02, 2016.

Breast Cancer is Only Pharmaceutical Pipeline with over 1000 Drugs in Development

March 2nd 2016

March 02, 2016.

PCORI Announces Initiative for Patient Access to of EHR Data

ByApplied Clinical Trials

February 29th 2016

Pharmaceutical Executive

February 29, 2016.

FDA Broadens Sentinel’s Assessment of Product Performance

ByJill Wechsler, Pharm Exec’s Washington Correspondent

February 26th 2016

February 26, 2016.

UK Biopharma Bosses Warn Against Brexit

February 25th 2016

February 25, 2016.

Parkinson's Disease Market Set for Moderate Growth to 2021

February 25th 2016

February 25, 2016.

What Lies Ahead for 2016: The DIA's Annual Report

ByDIA

February 24th 2016

February 24, 2016.

Senate Confirm Califf as FDA Commissioner

ByPharmaceutical Technology

February 24th 2016

Pharmaceutical Executive

February 25, 2016.

CVS Reports "Dramatic" Drop in Prescription Drug Trend

February 23rd 2016

February 23, 2016.

European Patients' Academy Launches R&D Toolbox

ByDIA

February 22nd 2016

February 22, 2016.

UK Pharma Companies Face £45 million in Pay-For-Delay Deal Fines

February 22nd 2016

February 22, 2016.

Reporting of Trial Results by Top Academic Centers Remains Poor, Says Study

ByPhilip Ward

February 19th 2016

Pharmaceutical Executive

February 19, 2016.

Translational Medicine: A “Team Sport”?

ByDIA

February 19th 2016

February 19, 2016

Technology

Latest News

FDA Moves to Increase Development of and Access to Abuse-deterrent Opioids

Pfizer Joins the Human Vaccines Project

UK: Industry Likely to Pay for NICE Technology Assessments

EMA Will Increase Fees on April 1

Trusting Value, Valuing Trust

WHO Emergency Committee Holds Second Meeting on Zika Virus

Califf Seeks Clinical Trials That Inform Product Labels

EGA Becomes Medicines for Europe

EMA Launches Priority Medicines Scheme

Drug Delivery Roundtable: More than the Pill

New Study Examines Overspending on Oversized Cancer Drug Vials

FDA to Address Opioid Trial Challenges

New Strategies Needed to Clarify Off-Label Marketing

Breast Cancer is Only Pharmaceutical Pipeline with over 1000 Drugs in Development

PCORI Announces Initiative for Patient Access to of EHR Data

FDA Broadens Sentinel’s Assessment of Product Performance

UK Biopharma Bosses Warn Against Brexit

Parkinson's Disease Market Set for Moderate Growth to 2021

What Lies Ahead for 2016: The DIA's Annual Report

Senate Confirm Califf as FDA Commissioner

CVS Reports "Dramatic" Drop in Prescription Drug Trend

European Patients' Academy Launches R&D Toolbox

UK Pharma Companies Face £45 million in Pay-For-Delay Deal Fines

Reporting of Trial Results by Top Academic Centers Remains Poor, Says Study

Translational Medicine: A “Team Sport”?

Trending on PharmExec

Boehringer Ingelheim Expands Immunology Pipeline With Preclinical Antibody Licensing Deal

Marty Makary Out as FDA Commissioner: Report

The Insight Gap: Biopharma’s Hidden Risk in the Race Against the Patent Cliff

From Consulting to Venture Capital: A Q&A with Gibb Witham, President of Hack The Box

Eli Lilly’s Foundayo and Lower-Dose Zepbound Helped Maintain Weight Loss in Patients Switching from Injectables